Recruitment: Participants will be recruited from one TIA/ 'minor' stroke assessment unit, based in the Ulster Hospital for the feasibility study and from 4 sites for the pilot study (Royal Victoria Hospital, Ulster Hospital, Antrim and Craigavon Area Hospitals). Patients are typically seen within one week of suffering neurological symptoms suggestive of TIA. After confirmation of diagnosis and initial management on the day of presentation, the attending physician will offer patients a study information sheet and an invitation to participate. If the patient agrees to being contacted, the researcher will telephone twenty-four hours later to invite them to attend the Clinical Research Facility, QUB to participate in the study and written, informed consent will be obtained. The numbers of those who decline to participate in the study will be recorded to provide information about recruitment rates.